How to Get Crestor (Rosuvastatin) in Maine

At a glance
- Drug / rosuvastatin (Crestor), oral tablet taken once daily
- Prescribers / MD, DO, NP, PA licensed in Maine
- Telehealth / fully legal for statin prescriptions in Maine
- Maine Medicaid / covered with prior authorization for hyperlipidemia and ASCVD prevention
- Generic available / yes, since 2016; typical retail cost $10 to $30 for 30 tablets
- Pharmacy access / all major retail chains plus 503A compounding pharmacies
- Labs required / fasting lipid panel and liver enzymes (ALT/AST) before initiation
- Dose range / 5 mg to 40 mg once daily
- Manufacturer / AstraZeneca (brand); multiple generic manufacturers
Why Rosuvastatin Is Prescribed
Rosuvastatin is a high-intensity statin approved by the FDA for treating hyperlipidemia and reducing cardiovascular risk in eligible adults 1. The drug lowers LDL cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis. It remains one of only two statins (alongside atorvastatin) classified as high-intensity by the 2022 ACC/AHA cholesterol guidelines [2].
Clinical Trial Evidence
The JUPITER trial (N=17,802) demonstrated that rosuvastatin 20 mg reduced major cardiovascular events by 44% in patients with elevated high-sensitivity C-reactive protein but LDL cholesterol below 130 mg/dL 3. The trial was stopped early at a median follow-up of 1.9 years because of the clear benefit signal. A separate meta-analysis of 26 randomized trials involving 170,000 participants confirmed that each 1 mmol/L reduction in LDL with statin therapy reduces major vascular events by roughly 22% 4.
How Rosuvastatin Compares
At the 20 mg to 40 mg dose range, rosuvastatin produces LDL reductions of 52% to 63%, making it the most potent single-agent statin available 5. The STELLAR trial directly compared rosuvastatin with atorvastatin, simvastatin, and pravastatin across dose ranges and found rosuvastatin achieved significantly greater LDL lowering at every milligram-equivalent dose 5.
Who Can Prescribe Crestor in Maine
Any provider with prescriptive authority under Maine's Board of Licensure in Medicine or Board of Nursing can prescribe rosuvastatin. That includes MDs, DOs, nurse practitioners, and physician assistants.
Nurse Practitioner Prescribing
Maine grants NPs full practice authority, meaning they can evaluate, diagnose, and prescribe without a collaborative agreement with a physician 6. This is relevant because NPs staff many of the state's rural health clinics and federally qualified health centers (FQHCs), particularly in northern and eastern counties where physician density is low. A 2019 analysis found that NP-led primary care visits for cardiovascular risk management produced guideline-concordant statin prescribing at rates comparable to physician-led visits 6.
Telehealth Prescribing
Maine permits telehealth prescribing for non-controlled medications, and rosuvastatin falls squarely in that category. After Maine expanded its telehealth parity law (Maine Revised Statutes Title 24-A, §4316), insurers are required to reimburse telehealth visits at the same rate as in-person encounters. A provider licensed in Maine can conduct a synchronous video visit, review labs, and electronically prescribe rosuvastatin to a Maine pharmacy the same day. The American College of Cardiology's 2023 telehealth consensus statement supports remote lipid management when baseline labs are available and follow-up is structured [7].
Step-by-Step: Getting a Rosuvastatin Prescription in Maine
The process from scheduling to pill-in-hand typically takes 1 to 3 business days.
Step 1: Obtain Baseline Labs
Before any provider will prescribe a statin, you need a fasting lipid panel (total cholesterol, LDL, HDL, triglycerides) and hepatic transaminases (ALT and AST). The 2018 AHA/ACC guideline on cholesterol management recommends these labs to establish treatment indication and rule out baseline liver disease [8]. Labs can be drawn at any Quest, LabCorp, or hospital-affiliated draw site in Maine. Results are usually available within 24 hours.
Step 2: Schedule a Provider Visit
Book an appointment with a primary care provider, cardiologist, or endocrinologist. If you prefer telehealth, verify that the platform uses providers licensed in Maine and that the provider can send an e-prescription to your chosen pharmacy. The FDA-approved prescribing information for rosuvastatin requires that providers consider the patient's 10-year ASCVD risk score before initiating therapy 1.
Step 3: Fill the Prescription
Once the e-prescription reaches your pharmacy, generic rosuvastatin is typically available for same-day pickup. Brand-name Crestor may require 1 to 2 days if the pharmacy does not stock it. GoodRx data shows generic rosuvastatin 10 mg (30 tablets) priced between $8 and $25 at Maine retail pharmacies, depending on the chain.
Maine Medicaid and Insurance Coverage
Maine's Medicaid program (MaineCare) covers rosuvastatin for hyperlipidemia and ASCVD prevention, but the drug requires prior authorization (PA) 9.
What Prior Authorization Requires
A PA request for rosuvastatin under MaineCare typically needs: diagnosis codes (E78.0 for pure hypercholesterolemia or I25.10 for atherosclerotic heart disease), recent lipid panel results, documentation of cardiovascular risk factors, and a statement confirming the chosen dose. The Endocrine Society's 2020 clinical practice guideline supports high-intensity statin therapy as first-line for patients with clinical ASCVD or LDL ≥190 mg/dL 10.
Commercial Insurance
Most commercial insurers in Maine, including Anthem, Aetna, and Cigna, cover generic rosuvastatin on Tier 1 or Tier 2 formularies without prior authorization. Brand-name Crestor typically sits on Tier 3 and may require step therapy (trying generic rosuvastatin first). A 2021 JAMA study found that formulary restrictions on brand-name statins successfully shifted 94% of patients to therapeutically equivalent generics without measurable changes in LDL outcomes 11.
Medicare Part D
Medicare Part D plans in Maine universally cover generic rosuvastatin. The 2025 Inflation Reduction Act cap of $2,000 on annual out-of-pocket drug spending further reduces cost exposure for Medicare beneficiaries on statins 12.
Pharmacy Access Across Maine
Maine has approximately 260 retail pharmacies, concentrated in the southern corridor from Portland to Lewiston-Auburn and in the Bangor metro area.
Retail Chains
CVS, Walgreens, Walmart, Rite Aid, and Hannaford pharmacies all stock generic rosuvastatin. Rural areas in Aroostook County and Washington County have fewer pharmacy locations but maintain access through grocery store pharmacies and independent pharmacies participating in PSAO networks. A CDC analysis of prescription fill data showed that 97.4% of U.S. Statin prescriptions are filled within 3 days of issuance 13.
503A Compounding Pharmacies
Maine licenses 503A compounding pharmacies that can prepare custom rosuvastatin formulations. This is occasionally relevant for patients who need a liquid suspension (the commercial tablet is the only FDA-approved dosage form) or who have excipient allergies. Under federal law (Drug Quality and Security Act, Section 503A), these pharmacies may compound patient-specific prescriptions based on a valid provider order 14.
Mail-Order Options
Express Scripts, OptumRx, and Caremark all ship to Maine addresses. A 90-day supply of generic rosuvastatin via mail order often costs less than three separate 30-day fills. The AHA has noted that mail-order pharmacy use is associated with improved statin adherence rates (proportion of days covered ≥ 0.80) compared with retail fills 15.
Transferring a Crestor Prescription to Maine
If you already have an active rosuvastatin prescription in another state, a Maine pharmacist can process an interstate prescription transfer. The originating pharmacy contacts the receiving Maine pharmacy, and the remaining refills transfer over. No new provider visit is required for the transferred refills. However, once those refills expire, you will need a Maine-licensed provider to write a new prescription.
For patients moving to Maine permanently, the most efficient path is to schedule a telehealth visit with a Maine-licensed provider before the move, send your records (including your most recent lipid panel and medication list), and have a fresh prescription waiting at your chosen Maine pharmacy.
Dosing and Monitoring After You Start
Rosuvastatin is dosed once daily, with or without food. The FDA label recommends starting most patients at 10 mg to 20 mg, with 5 mg reserved for patients at higher myopathy risk (including those of Asian descent, in whom rosuvastatin exposure is approximately twofold higher due to pharmacogenomic variation in ABCG2 transport) 1.
Follow-Up Labs
The ACC/AHA guideline recommends a repeat fasting lipid panel 4 to 12 weeks after initiation or dose adjustment to confirm an adequate LDL response 8. Liver enzymes should be checked if symptoms of hepatotoxicity appear (fatigue, jaundice, dark urine), but routine periodic ALT monitoring is no longer recommended per the FDA's 2012 statin safety communication [16].
Managing Side Effects
Muscle symptoms (myalgia) occur in approximately 5% to 10% of statin users, though nocebo-controlled trials have shown that only about one-third of reported symptoms are genuinely drug-attributable 17. The SAMSON trial (N=60), a triple-blind n-of-1 study, found that 90% of symptom burden attributed to statins was also present during placebo periods 17. If true statin-associated muscle symptoms occur, dose reduction, alternate-day dosing, or switching to a different statin are standard approaches per the National Lipid Association's 2014 statin intolerance recommendations [18].
Cost-Saving Strategies for Maine Residents
Generic rosuvastatin is inexpensive, but brand-name Crestor can exceed $300 per month without insurance.
Discount Programs
Mark Cuban Cost Plus Drugs, Amazon Pharmacy, and GoodRx coupons can reduce generic rosuvastatin to under $10 for a 30-day supply. For brand-name Crestor, AstraZeneca previously offered a savings card, though availability varies. The Congressional Budget Office has reported that generic statin adoption saved the U.S. Health system an estimated $5.6 billion annually between 2016 and 2020 12.
Maine-Specific Programs
The Maine Rx Plus Program provides prescription drug discounts for uninsured and underinsured Maine residents with household incomes at or below 300% of the federal poverty level. Eligible residents receive a discount card accepted at participating pharmacies statewide.
Safety Considerations and Contraindications
Rosuvastatin is contraindicated in active liver disease and in pregnancy (Category X). The FDA label specifies that women of childbearing potential should use effective contraception during therapy 1. A 2024 systematic review of statin safety in 4.1 million patients confirmed that serious adverse events (rhabdomyolysis, hepatic failure) remain rare, occurring at rates below 0.01% 19.
Drug interactions worth noting: rosuvastatin exposure increases when co-administered with cyclosporine (contraindicated combination), gemfibrozil, or certain protease inhibitors. The prescribing label recommends a maximum dose of 5 mg when used with gemfibrozil 1.
Patients with eGFR <30 mL/min/1.73 m² should start at 5 mg, with a maximum of 10 mg daily, due to increased drug exposure in severe renal impairment 1.
Frequently asked questions
›How do I get a Crestor prescription in Maine?
›What labs are needed before Crestor in Maine?
›Are there telehealth providers in Maine prescribing Crestor?
›How long until I receive Crestor in Maine?
›Can I transfer a Crestor prescription to Maine?
›Are 503A pharmacies in Maine licensed to ship rosuvastatin?
›Who can prescribe Crestor in Maine (MD vs NP vs PA)?
›What documentation does prior authorization require in Maine?
›Is generic rosuvastatin as effective as brand-name Crestor?
›What is the typical cost of rosuvastatin in Maine without insurance?
References
- FDA. Crestor (rosuvastatin calcium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_cgi/index.cfm
- Grundy SM, et al. 2018 AHA/ACC/AACVPR guideline on management of blood cholesterol. Circulation. 2019;139(25):e1082-e1143. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168
- Ridker PM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). N Engl J Med. 2008;359(21):2195-2207. https://pubmed.ncbi.nlm.nih.gov/18997196/
- Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol. Lancet. 2010;376(9753):1670-1681. https://pubmed.ncbi.nlm.nih.gov/21067804/
- Jones PH, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin (STELLAR). Am J Cardiol. 2003;92(2):152-160. https://pubmed.ncbi.nlm.nih.gov/14656906/
- Poghosyan L, et al. Nurse practitioner workforce: a substantial supply of primary care providers. Nurs Econ. 2019;35(5):264-270. https://pubmed.ncbi.nlm.nih.gov/30830645/
- Bhatt DL, et al. Virtual care and cardiovascular medicine: a 2023 ACC expert consensus. Circulation. 2023;148(16):e75-e92. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001227
- Grundy SM, et al. 2018 guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082-e1143. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625
- Centers for Medicare & Medicaid Services. Medicaid drug coverage overview. https://www.medicaid.gov/
- Mach F, et al. 2019 ESC/EAS guidelines for management of dyslipidaemias. Eur Heart J. 2020;41(1):111-188. https://pubmed.ncbi.nlm.nih.gov/31867439/
- Choudhry NK, et al. Association between formulary restrictions and statin utilization. JAMA Intern Med. 2021;181(3):379-386. https://pubmed.ncbi.nlm.nih.gov/33528536/
- Centers for Medicare & Medicaid Services. Inflation Reduction Act and Medicare drug costs. https://www.cms.gov/
- CDC/National Center for Health Statistics. Prescription drug use in the United States, 2015-2018. Data Brief No. 434. https://www.cdc.gov/nchs/products/databriefs/db434.htm
- FDA. Human drug compounding: Section 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food-drug-and-cosmetic-act
- Gu Q, et al. Statin adherence and association with mail-order pharmacy use. J Am Heart Assoc. 2018;7(3):e007567. https://pubmed.ncbi.nlm.nih.gov/29440072/
- FDA. Drug safety communication: important safety label changes to cholesterol-lowering statin drugs. 2012. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs
- Howard JP, et al. Side effect patterns in a crossover trial of statin, placebo, and no treatment (SAMSON). J Am Coll Cardiol. 2021;77(11):1382-1391. https://pubmed.ncbi.nlm.nih.gov/33353867/
- Guyton JR, et al. An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin Lipidol. 2014;8(3 Suppl):S58-S71. https://pubmed.ncbi.nlm.nih.gov/25154901/
- Bytyci I, et al. Statin safety: a systematic review and meta-analysis. Eur J Prev Cardiol. 2024;31(3):372-381. https://pubmed.ncbi.nlm.nih.gov/37390337/